Term
|
Definition
The process of developing an immune response to self antigens. |
|
|
Term
Autoimmune Hemolytic Anemia |
|
Definition
Antibodies are raised against cell surface antigens on red blood cells, resulting in destruction of red cells and anemia. |
|
|
Term
Cold hemagglutinin disease |
|
Definition
A type of hemolytic anemia from and IgM response. The antibodies agglutinate cells with increasing strenght as teh temperature drops. Extensive hemolysis occurs when arms, legs, adn extremities drop below 37 degrees C in cold weather. |
|
|
Term
|
Definition
Antibodies develop against receptors for thyroid-stimulating hormone. |
|
|
Term
Thyroid Stimulating Hormone |
|
Definition
Antibodies are developed against receptors for this in Graves' disease. |
|
|
Term
|
Definition
Autoantibodies against acetylcholine receptors at the neuromuscular junction. |
|
|
Term
|
Definition
In myasthenia gravis, autoantibodies are made against these receptors at the neuromuscular junciton. |
|
|
Term
Systemic lupus erythematosus |
|
Definition
systemic autoimmune disease in which autoantibodies made against DNA, RNA, and nucleoprotein particles form immune complexes that damage small blood vessels. |
|
|
Term
|
Definition
Important for controlling extracellular bacteria and fungi. |
|
|
Term
|
Definition
Important for immunosuppression. |
|
|
Term
|
Definition
Autoimmune response agains the myelin sheath of nerve cells. Involves demyelination of CNS tissue resulting in sclerotic plaques of demyelinated tissues. |
|
|
Term
Experimental allergic encephalomyelitis |
|
Definition
caused by immunizing rats or mice with myelin basic protein, a protein foudn in myelin sheath that surrounds nerve cell axons in the brain and spinal cord. Mice develop T cells specific for myelin basic protein. |
|
|
Term
|
Definition
Chronically inflamed joints infiltrated by multiple immune cells. |
|
|
Term
Hypersensitivity Reaction |
|
Definition
An inappropriate immune response. Body recognizes and responds to some foreign antigen that isn't directly related to a protective response against a pathogen. |
|
|
Term
|
Definition
|
|
Term
|
Definition
immune reactions against allergens. |
|
|
Term
Type I hypersensitivity reaction |
|
Definition
IgE mediated, antigens binding to IgE boudn to Falpha receptros on mast cells. |
|
|
Term
Type II hypersensitivity Reaction |
|
Definition
antibody-mediated, antibodies bind to antigens bound to cell or matrix surface. |
|
|
Term
Type III hypersensitivity reaction |
|
Definition
immune complex-mediated, antibodies bind to soluble antigens. |
|
|
Term
Type IV hypersensitivity reaction |
|
Definition
mediated by antigen-specific T cells, also known as delayed-type hypersensitivity. |
|
|
Term
Delayed-type hypersensitivity |
|
Definition
Mediated by antigen-specific T cells (Type IV) |
|
|
Term
|
Definition
Original exposure to an antigen where a person makes IgE antibodies against the antigen. |
|
|
Term
|
Definition
Inherited predisposition to the production of IgE against common environmental antigens. |
|
|
Term
|
Definition
Fc receptors on the surface of basophils, mast cells, and activated eosinophils that bind to IgE with high affinity |
|
|
Term
|
Definition
originate in bone marrow and travel to peripheral mucosal and epithelial tissue where they undergo maturation. They have lots of cytoplasmic granules containg preformed inflammatory mediators like histmine, heparin, TNF-alpha, and various proteases. |
|
|
Term
|
Definition
granulocytes mostly resident in tissues. Express FcRI receptors only after activation. Release highly toxic mediators and enzymes that can cause tissue damage. Normal function is to kill parasites directly. |
|
|
Term
|
Definition
are low abundance granulocytes that circulate in the blood. Conain a similar set of mediators in the granules as mast cells. Also produce IL-4 and IL-13 to promote TH2 responses. |
|
|
Term
|
Definition
major granule constituent. Binds to histamine H1 receptors son smooth muscle cells to rapidly induce bronchial and intestinal smooth muscle contraction, binds to endothelial cells to increase vascular permeability, increases mucus secretion from epithelial cells. |
|
|
Term
|
Definition
Cause smooth muscle contraction, increase vascular permeability, and causes mucus secretions. |
|
|
Term
|
Definition
Due to release of preformed mediators. |
|
|
Term
|
Definition
Due to mediators and synthesized following mast cell stimulation |
|
|
Term
|
Definition
the consequence of an immediate response. |
|
|
Term
|
Definition
activation of nasal mucosal mast cells. |
|
|
Term
|
Definition
Allergic response in the eye. |
|
|
Term
|
Definition
degranulation of mast cells in the lower respiratory tract in response to allergen. |
|
|
Term
|
Definition
activation of mast cells in the skin cause histamine release resulting in itchy swellings. |
|
|
Term
|
Definition
Allergen enters the bloodstream causing widespred increases in vascular permeability-large loss of blood pressure. |
|
|
Term
|
Definition
Incidence of asthma and other allergic diseases in developing countries is on the increase. |
|
|
Term
|
Definition
Bind to histamine receptors to block binding of histamine. |
|
|
Term
|
Definition
treatment with increasing doses of antigen in an attempt to switch from IgE to IgG response or to generate Treg cells that secrete TGFB adn IL-10 |
|
|
Term
Antibody-dependent cell-mediated cytotoxicity |
|
Definition
triggered by immunoglobulins other than IgE binding to cells in the body resulting in destruction of cells by this process. |
|
|
Term
|
Definition
A potentially fatal disease caused by maternal IgG antibodies directed toward paternal antigens expressed on fetal red blood cells. The usual target of this response is the Rh blood group antigen. |
|
|
Term
|
Definition
|
|
Term
|
Definition
localize IgG mediated reaction. |
|
|
Term
|
Definition
receptor on mast cells that has a low affinity and binds to complexes of antigen and igG. |
|
|
Term
|
Definition
moldy hay, caused by development of antibodies against mold spores. |
|
|
Term
|
Definition
Patients treated with antisera can develop an immune response against foreign serum proteins leading to accumulation of antibody-antigen complexes. |
|
|
Term
Pentadecacatechol/urushiol |
|
Definition
a contact dermatitis response. |
|
|
Term
|
Definition
getting a hypersensitivity response to something like poison ivy. |
|
|
Term
|
Definition
occurs in response to dietary gluten, TH1 mediated. |
|
|
Term
|
Definition
a drug induced type IV hypersensitivity that results in skin disorders. |
|
|
Term
|
Definition
a skin test to determine if someone was previously infected with mycobacterium TB. |
|
|
Term
|
Definition
IgM antibody with specificity for human IgG that is produced in some people with rheumatoid arthritis. |
|
|
Term
|
Definition
Destruction of the insulin-producing Beta cells of the pancreas by an autoimmune response. |
|
|
Term
|
Definition
transcription factor that causes several hundred tissue-specific genes to be trascribed by a subpopulation of epithelial cells in the medulla of the thymus, and which thus enables the developing T-cell population to become tolerant of antigens that normally function only outside the thymus. |
|
|
Term
|
Definition
several independently segregating disease susceptibility loci exist. |
|
|
Term
|
Definition
an example of when trauma can cause disruption of cell or tissue barrier allowing a formerly sequestered antigen to become recognized. |
|
|
Term
|
Definition
Antibodies or T cells generated in response to an infectious agent cross-react with self antigens. |
|
|
Term
|
Definition
Autoimmune disease involving inflammation of the heart, joints, and kidneys, which can follow 2-3 weeks after a throat infection. |
|
|
Term
|
Definition
Signal is recognized and then spread somewhere else. |
|
|
Term
|
Definition
Can stimulate T cells without engagement of TCR. |
|
|
Term
|
Definition
exposure to infectious organism or antigens from an infectious organism to generate an immunological memory to repel any later invasions by the same organism. |
|
|
Term
|
Definition
Historical procedure for immunization against small-pox in which a small amount of live smallpox virus was introduced through scarification of the skin. |
|
|
Term
|
Definition
virus treated with heat or irradiation or chemicals so it cannot replicate further. Basis of salk polio vaccine. |
|
|
Term
|
Definition
Live virus mutated so that it doesn't grwo very well in human cells. Basis of Sabin polio vaccine, measles, mumps, rubella. |
|
|
Term
|
Definition
Take an infectious agent and alter it so that it becomes harmless or less virulent. |
|
|
Term
|
Definition
surface components of the virus are used as immunogens for the production of neutralizing antibodies. |
|
|
Term
|
Definition
the body produces neutralizing antibodies against a surface protein knon as HBsAg. |
|
|
Term
|
Definition
reassortant strains are created from parent animal strains that contain human genes that code for a human protein. |
|
|
Term
|
Definition
derived from a bovine strain of mycobacterium TB and is used to provide protection TB. |
|
|
Term
|
Definition
|
|
Term
|
Definition
the agent responsible for whooping cough, initially involved injection of whole killed bacteria as a form of a vaccine. |
|
|
Term
|
Definition
vaccine contains components against which immune responses were normally mounted. |
|
|
Term
|
Definition
A vaccine made from capsular polysaccharides bound to an immunogenic protein such as tetanus toxoid. the protein provides peptide epitopes that stimulate CD4 T cells to help B cells specific for the polysaccharide. |
|
|
Term
|
Definition
causes bacterial meningitis. |
|
|
Term
|
Definition
exists in multiple serotypes, difficult to make a vaccine against. |
|
|
Term
|
Definition
needed to induce inflammation, permit antigen uptake into APCs adn keep antigen at injection site for slow release. |
|
|
Term
|
Definition
|
|
Term
|
Definition
a combined mixture of antigens for diphtheria, tetanus, and acellular pertussis. |
|
|
Term
Pneumococcal conjugate vaccine |
|
Definition
directed against Streptococcus pneumoniae heptavalent |
|
|
Term
|
Definition
has many viral components, used in Influenza. |
|
|
Term
measles, mumps and rubella |
|
Definition
all live, attenuated viruses that are injected simultaneously. |
|
|
Term
|
Definition
for varicella-zoster virus, which causes chickenpox-live attenuated virus. |
|
|
Term
|
Definition
|
|
Term
|
Definition
conjugate virus, only kids over 2 if in a high risk group. |
|
|
Term
|
Definition
tetanus toxiod, diphtheria toxoids, and acellular pertussis vaccine. |
|
|
Term
|
Definition
a non-infectious recombinant, quadrivalent vaccine prepared for highly purified virus-like particlesof the major capsid protein of HPV. |
|
|
Term
|
Definition
cell-free filtrate produced from a strain of anthrax that does not cause disease. Contains one of 3 toxin proteins known as protective antigen. |
|
|
Term
|
Definition
a way to update the methodology for producing vaccines for influenza and other viruses. |
|
|
Term
|
Definition
present antigen in an accessible, multimeric, physically well-defined complex. |
|
|
Term
|
Definition
Plasmid altered to carry a gene specifying one or more antigenic proteins normally made by a selected pathogen. |
|
|
Term
|
Definition
Results from transfer of antibody from one individual to another. |
|
|
Term
Artificial passive immunity |
|
Definition
protects a susceptible individual by directly administering exogenous supplemental immunoglobulins obtained from an immune donor. |
|
|
Term
|
Definition
treatment with antibody from a different species. |
|
|
Term
|
Definition
pooled human immune globulin. |
|
|
Term
Rhesus incompatibility reaction |
|
Definition
leads to erythroblastosis fetalis or hemolytic disease of the newborn. |
|
|